{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T23:17:05Z","timestamp":1795216625262,"version":"4.10.3"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review explores mechanisms by which gut-derived bacterial<\/jats:p>\n            <jats:p>lipopolysaccharide (LPS) and oxidized phospholipids contribute to chronic systemic inflammation and atherosclerosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Gut-derived LPS enters through the small intestine via two distinct pathways that involve high density lipoproteins (HDL) and chylomicrons. Gut-derived LPS can bind to the LPS-binding protein (LBP) and to HDL<jats:sub>3<\/jats:sub> in the small intestine and travel through the portal vein to the liver where it does not elicit an inflammatory reaction, and is inactivated or it can bind to HDL<jats:sub>2<\/jats:sub> and travel through the portal vein to the liver where it elicits an inflammatory reaction. Alternatively, in the small intestine, LPS can bind to LBP and chylomicrons and travel through the lymphatics to the systemic circulation and enhance inflammatory processes including atherosclerosis. Oxidized phospholipids formed in the small intestine regulate the levels and uptake of LPS in small intestine by regulating antimicrobial proteins such as intestinal alkaline phosphatase. Gut-derived LPS and oxidized phospholipids may be responsible for the persistent inflammation seen in some persons with human immunodeficiency virus on potent antiretroviral therapy with undetectable virus levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>By targeting gut-derived oxidized phospholipids, the uptake of gut-derived LPS may be reduced to decrease systemic inflammation and atherosclerosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mol.0000000000000841","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T08:00:06Z","timestamp":1660809606000},"page":"277-282","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":26,"title":["The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis"],"prefix":"10.1097","volume":"33","author":[{"given":"Huan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasa T.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology"},{"name":"Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Fogelman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"key":"R1-20250729","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"R2-20250729","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/1873-3468.14328","article-title":"Lipopolysaccharide and the gut microbiota: considering structural variation","volume":"596","author":"Mohr","year":"2022","journal-title":"FEBS Lett"},{"key":"R3-20250729","first-page":"178","article-title":"The intestinal microbiome in human health and disease","volume":"131","author":"Dupont","year":"2020","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R4-20250729","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","article-title":"Association of endotoxemia with carotid atherosclerosis and cardiovascular disease. Prospective results from the Bruneck Study","volume":"34","author":"Wiedermann","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R5-20250729","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(98)09286-1","article-title":"Endotoxin and immune activation in chronic heart failure: a prospective cohort study","volume":"353","author":"Niebaure","year":"1999","journal-title":"Lancet"},{"key":"R6-20250729","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.103.8.1064","article-title":"Chronic infections and the risk of carotid atherosclerosis. Prospective results from a large population study","volume":"103","author":"Kiechl","year":"2001","journal-title":"Circulation"},{"key":"R7-20250729","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1388-9842(03)00104-1","article-title":"Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure","volume":"5","author":"Peschel","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"R8-20250729","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jacc.2007.02.070","article-title":"Association of lipopolysaccharide-binding protein and coronary artery disease in men","volume":"50","author":"Lepper","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R9-20250729","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.atherosclerosis.2013.07.004","article-title":"Serum lipopolysaccharide-binding protein as a marker of atherosclerosis","volume":"230","author":"Serrano","year":"2013","journal-title":"Atherosclerosis"},{"key":"R10-20250729","doi-asserted-by":"crossref","first-page":"e54600","DOI":"10.1371\/journal.pone.0054600","article-title":"Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population. The role of obesity","volume":"8","author":"Gonzalez-Quintela","year":"2013","journal-title":"PLoS One"},{"key":"R11-20250729","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/dc15-1777","article-title":"Association of lipopolysaccharide-binding protein with aging-related adiposity change and prediabetes among African ancestry men","volume":"39","author":"Tilves","year":"2016","journal-title":"Diabetes Care"},{"key":"R12-20250729","doi-asserted-by":"crossref","first-page":"e005784","DOI":"10.1161\/JAHA.117.005784","article-title":"Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: effect of adherence to Mediterranean diet","volume":"6","author":"Pastori","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R13-20250729","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1038\/s41598-018-22076-4","article-title":"Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque","volume":"8","author":"Carnevale","year":"2018","journal-title":"Sci Rep"},{"key":"R14-20250729","doi-asserted-by":"crossref","first-page":"e013628","DOI":"10.1161\/JAHA.119.013628","article-title":"Serum lipopolysaccharide-binding protein levels and the incidence of cardiovascular disease in a general Japanese population. The Hisayama Study","volume":"8","author":"Asada","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"R15-20250729","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/s41598-021-86083-8","article-title":"Bacterial lipopolysaccharide is associated with stroke","volume":"11","author":"Hakoupian","year":"2021","journal-title":"Sci Rep"},{"key":"R16-20250729","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1073\/pnas.83.8.2704","article-title":"The role of lipoproteins and receptor mediated-endocytosis in the transport of bacterial lipopolysaccharide","volume":"83","author":"Van Lenten","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"R17-20250729","doi-asserted-by":"crossref","first-page":"34116","DOI":"10.1074\/jbc.274.48.34116","article-title":"Plasma lipoproteins promote the release of bacterial lipoprotein from the monocyte cell surface","volume":"274","author":"Kitchens","year":"1999","journal-title":"J Biol Chem"},{"key":"R18-20250729","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1172\/JCI10832","article-title":"LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL\/VLDL interaction","volume":"107","author":"Vreugdenhil","year":"2001","journal-title":"J Clin Invest"},{"key":"R19-20250729","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1194\/jlr.M800156-JLR200","article-title":"Chylomicrons promote intestinal absorption of lipopolysaccharides","volume":"50","author":"Ghoshal","year":"2009","journal-title":"J Lipid Res"},{"key":"R20-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1194\/jlr.E800018-JLR200","article-title":"Endotoxin in the gut and chylomicrons: translocation or transportation?","volume":"50","author":"Grunfeld","year":"2009","journal-title":"J Lipid Res"},{"key":"R21-20250729","doi-asserted-by":"crossref","first-page":"E1245","DOI":"10.1210\/jc.2013-3463","article-title":"Changes in lipoprotein kinetics associated with Type 2 diabetes affect the distribution of lipopolysaccharides among lipoproteins","volume":"99","author":"Verges","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20250729","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1210\/jc.2015-2518","article-title":"Postprandial endotoxemia linked with chylomicrons and lipopolysaccharides handling in obese versus lean men: a lipid dose-effect trial","volume":"100","author":"Vors","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20250729","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00098.2016","article-title":"Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation","volume":"311","author":"Gueville","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R24-20250729","doi-asserted-by":"crossref","first-page":"e0155030","DOI":"10.1371\/journal.pone.0155030","article-title":"Lipopolysaccharide is cleared from the circulation by hepatocytes via the low density lipoprotein receptor","volume":"11","author":"Topchiy","year":"2016","journal-title":"PLoS One"},{"key":"R25-20250729","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S0954422417000269","article-title":"Role of microbiota-derived lipopolysaccharide in adipose tissue inflammation, adipocyte size and pryoptosis during obesity","volume":"31","author":"Hersoug","year":"2018","journal-title":"Nutr Res Rev"},{"key":"R26-20250729","doi-asserted-by":"crossref","first-page":"10496","DOI":"10.1038\/s41598-018-28777-0","article-title":"Low-density lipoprotein (LDL)-dependent uptake of lipoteichoic acid and gram-negative lipopolysaccharide occurs through LDL receptor","volume":"8","author":"Grin","year":"2018","journal-title":"Sci Rep"},{"key":"R27-20250729","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1194\/jlr.RA120001132","article-title":"LDL apheresis as an alternate method for plasma LPS purification in healthy volunteers and dyslipidemic and septic patients","volume":"61","author":"Dargent","year":"2020","journal-title":"J Lipid Res"},{"key":"R28-20250729","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/biom12010047","article-title":"Characterization of the LPS 3OHFA contents in the lipoprotein fractions and lipoprotein particles of healthy men","volume":"12","author":"Rehues","year":"2022","journal-title":"Biomolecules"},{"key":"R29-20250729","doi-asserted-by":"crossref","first-page":"eabe6729","DOI":"10.1126\/science.abe6729","article-title":"Enterically derived high-density lipoprotein restrains liver injury through the portal vein","volume":"373","author":"Han","year":"2021","journal-title":"Science"},{"key":"R30-20250729","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1172\/JCI113359","article-title":"Low density lipoproteins transfer bacterial lipopolysaccharides across endothelial monolayers in a biologically active form","volume":"81","author":"Navab","year":"1988","journal-title":"J Clin Invest"},{"key":"R31-20250729","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J Clin Invest"},{"key":"R32-20250729","doi-asserted-by":"crossref","first-page":"15064","DOI":"10.1073\/pnas.0803124105","article-title":"The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria","volume":"105","author":"Johansson","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R33-20250729","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1073\/pnas.1006451107","article-title":"The two mucus layers of colon are organized by the Muc2 mucin, whereas the outer layer is a legislator of host-microbial interactions","volume":"108","author":"Johansson","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R34-20250729","doi-asserted-by":"crossref","first-page":"G922","DOI":"10.1152\/ajpgi.2001.280.5.G922","article-title":"The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo","volume":"280","author":"Atuma","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R35-20250729","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00046.2013","article-title":"Studies of mucus in mouse stomach, small intestine and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches","volume":"305","author":"Ermund","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R36-20250729","doi-asserted-by":"crossref","first-page":"100153","DOI":"10.1016\/j.jlr.2021.100153","article-title":"Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation","volume":"63","author":"Mukherjee","year":"2022","journal-title":"J Lipid Res"},{"key":"R37-20250729","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0022-2275(20)31599-6","article-title":"Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide","volume":"42","author":"Datta","year":"2001","journal-title":"J Lipid Res"},{"key":"R38-20250729","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1194\/jlr.M800075-JLR200","article-title":"Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I","volume":"49","author":"Van Lenten","year":"2008","journal-title":"J Lipid Res"},{"key":"R39-20250729","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1194\/jlr.M033555","article-title":"A novel approach to oral apoA-I mimetic therapy","volume":"54","author":"Chattopadhyay","year":"2013","journal-title":"J Lipid Res"},{"key":"R40-20250729","doi-asserted-by":"crossref","first-page":"e108577","DOI":"10.1371\/journal.pone.0108577","article-title":"Oral supplementation with nonabsorbable antibiotics or curcumin attenuates Western diet-induced atherosclerosis and glucose intolerance in LDLR-\/- mice - role of intestinal permeability and macrophage activation","volume":"9","author":"Ghosh","year":"2014","journal-title":"PLoS One"},{"key":"R41-20250729","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/jendso\/bvz039","article-title":"Intestinal barrier dysfunction, LPS translocation, and disease development","volume":"4","author":"Ghosh","year":"2020","journal-title":"J Endocr Soc"},{"key":"R42-20250729","first-page":"e13790","article-title":"Intestine-specific expression of human chimeric intestinal alkaline phosphatase attenuates Western diet-induced barrier dysfunction and glucose intolerance","volume":"6","author":"Ghosh","year":"2018","journal-title":"Phys Rep"},{"key":"R43-20250729","doi-asserted-by":"crossref","first-page":"e89374","DOI":"10.1371\/journal.pone.0089374","article-title":"Catalytic signature of a heat-stable, chimeric human alkaline phosphatase with therapeutic potential","volume":"9","author":"Kiffer-Moreira","year":"2014","journal-title":"PLoS One"},{"key":"R44-20250729","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/CIRCRESAHA.120.317144","article-title":"Over-expression of intestinal alkaline phosphatase attenuates atherosclerosis","volume":"128","author":"Ghosh","year":"2021","journal-title":"Cir Res"},{"key":"R45-20250729","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/CIRCRESAHA.121.319307","article-title":"mInd the gAP Inestinal alkaline phosphatase puts the breaks on atherosclerosis","volume":"128","author":"de Aguiar Vallim","year":"2021","journal-title":"Circ Res"},{"key":"R46-20250729","doi-asserted-by":"crossref","first-page":"e26631","DOI":"10.1097\/MD.0000000000026631","article-title":"Cardiovascular disease and prevention among people living with HIV in South Florida","volume":"100","author":"Pyarali","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R47-20250729","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/infdis\/jix039","article-title":"Human immunodeficiency virus persistence and T-cell activation in blood, rectal and lymph node tissue in human immunodeficiency virus-infected individuals receiving suppressive antiretroviral therapy","volume":"215","author":"Khoury","year":"2017","journal-title":"J Infect Dis"},{"key":"R48-20250729","doi-asserted-by":"crossref","first-page":"e2018099","DOI":"10.1001\/jamanetworkopen.2020.18099","article-title":"Association of viral persistence and atherosclerosis in adults with treated HIV infection","volume":"3","author":"McLaughlin","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R49-20250729","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0000000000002785","article-title":"Apolipoprotein A-I mimetics attenuate macrophage activation in chronic treated HIV","volume":"35","author":"Mu","year":"2021","journal-title":"AIDS"},{"key":"R50-20250729","doi-asserted-by":"crossref","first-page":"154888","DOI":"10.1016\/j.metabol.2021.154888","article-title":"ApoA-I mimetics favorably impact cyclooxygenase 2 and bioactive lipids that may contribute to cardiometabolic syndrome in chronic HIV","volume":"124","author":"Daskou","year":"2021","journal-title":"Metab Clin Exp"},{"key":"R51-20250729","doi-asserted-by":"crossref","first-page":"e1010160","DOI":"10.1371\/journal.ppat.1010160","article-title":"ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV","volume":"18","author":"Daskou","year":"2022","journal-title":"PLoS Pathog"},{"key":"R52-20250729","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/jiw263","article-title":"Plasma soluble CD163 level independently predicts all-cause mortality in HIV-1-infected individuals","volume":"214","author":"Knudsen","year":"2016","journal-title":"J Infect Dis"}],"container-title":["Current Opinion in Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000841","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T22:03:57Z","timestamp":1753826637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOL.0000000000000841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mol.0000000000000841","relation":{},"ISSN":["0957-9672","1473-6535"],"issn-type":[{"value":"0957-9672","type":"print"},{"value":"1473-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]}}}